DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
- Authors:
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC
- Unidade: IFSC
- DOI: 10.2174/0929867329666220620162018
- Subjects: DOENÇA DE ALZHEIMER; INIBIDORES DE ENZIMAS
- Keywords: Alzheimer's disease; Neurodegeneration; Protein kinases; Enzyme kinetics; DYRK1A inhibitors; Molecular docking
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Medicinal Chemistry
- ISSN: 0929-8673
- Volume/Número/Paginação/Ano: v. 30, n. 6, p. 669-688, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 13 fev. 2026. -
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018 -
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2026 fev. 13 ] Available from: https://doi.org/10.2174/0929867329666220620162018 -
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2026 fev. 13 ] Available from: https://doi.org/10.2174/0929867329666220620162018 - Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity
- Quantitative structure-activity relationships for structurally diverse chemotypes having anti-Trypanosoma cruzi activity
- Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- COVID-19: small-molecule clinical trials landscape [Editorial]
- Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
- In vitro leishmanicidal activity of novel N-arylspermidine derivatives
- Chemoinformatics approaches to structure- and ligand-based drug design
- Empowering neglected tropical disease drug discovery with translational medicinal chemistry. [Editorial]
Informações sobre o DOI: 10.2174/0929867329666220620162018 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
PROD033747_3111047.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
